The Global Platelet Aggregation Devices Market Is Poised to Reach $342.4
Million by 2020, Growing at a CAGR of 21.0% from 2015 to 2020

On the basis of products, the global platelet aggregation devices market is
classified into three major segments, namely, systems, reagents, and
consumables & accessories. On the basis of applications, the global
platelet aggregation devices market is classified into research applications
and clinical applications. The clinical applications segment is further
classified into three subsegments, namely, cardiovascular, orthopedic, and
other clinical applications (includes monitoring of antiplatelet therapy and
urology, trauma, and bleeding disorders).

Factors such as rising incidences of target diseases, rapid growth in the
geriatric population across the globe, technological advancements in platelet
aggregometers, and increasing number of industry-academia collaborations and
clinical studies are fuelling the growth of the global platelet aggregation
devices market. On the other hand, procedural limitations, unfavorable
healthcare reforms in the U.S., and dearth of well trained and skilled
professionals are some of the key factors hampering the growth of this market.

As of 2015, North America is expected to hold the largest share of the
platelet aggregation devices market, followed by Europe. Additionally, North
America is expected to grow at the highest CAGR during the forecast period
(2015 to 2020). Strong market growth witnessed in the North American platelet
aggregation devices market can be attributed to factors such as large patient
population for target diseases; strong presence of device manufacturers in the
region; growing number of surgical procedures; rising awareness among
healthcare professionals (regarding the benefits offered by platelet
aggregation testing in disease diagnosis); large number of patients undergoing
cardiovascular surgeries; and increasing prevalence of orthopedic, urological,
and bleeding disorders. F. Hoffmann La-Roche Ltd. (Switzerland), Haemonetics
Corporation (U.S.), Sysmex Corporation (Japan), Siemens AG (Germany), Accriva
Diagnostics (U.S.), Helena Laboratories Corporation (U.S.), Bio/Data Corporation
(U.S.), Tem Group (Switzerland), Sentinel CH. S.p.A. (Italy), and Aggredyne,
Inc. (U.S.) are the major players in the global platelet aggregation devices
market.

Markets and Markets is world’s No. 2 firm in terms of annually published
premium market research reports. Serving 1700 global fortune enterprises with
more than 1200 premium studies in a year, M&M is catering to multitude of
clients across 8 different industrial verticals. We specialize in consulting
assignments and business research across high growth markets, cutting edge
technologies and newer applications. Our 850 fulltime analyst and SMEs at
Markets and Markets are tracking global high growth markets following the
"Growth Engagement Model – GEM". The GEM aims at proactive
collaboration with the clients to identify new opportunities, identify most
important customers, write "Attack, avoid and defend" strategies,
identify sources of incremental revenues for both the company and its
competitors.

M&M’s flagship competitive intelligence and market research platform,
"RT" connects over 200,000 markets and entire value chains for deeper
understanding of the unmet insights along with market sizing and forecasts of
niche markets. The new included chapters on Methodology and Benchmarking
presented with high quality analytical infographics in our reports gives
complete visibility of how the numbers have been arrived and defend the
accuracy of the numbers.

We at Markets and Markets are inspired to help our clients grow by providing
apt business insight with our huge market intelligence repository.